{"pr_nif_0000_21981_1": {
  "e_uid": "NIDA-CSP-1008A",
  "studynum": "NIDA-CSP-1008A",
  "investigator": "Peter Bridge, M.D., Paul J. Fudala, Ph.D.",
  "study_title": "A Multicenter Efficacy/Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence",
  "release_date": "2014-12-04",
  "study_description": "This 52-week study is designed to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment. The developmental objective for this combination product is an expansion of therapeutic options for the treatment of opiate dependence.",
  "keywords": "Phase 3, Buprenorphine, Naloxone, Opiate",
  "url": "https://datashare.nida.nih.gov/protocol/nida-csp-1008a",
  "v_uid": "NIDA-CSP-1008A",
  "v_uuid": "ae705bf4-2053-5de1-8ce7-884a5400f55b",
  "v_lastmodified": "2016-04-07 12:43:22.048079",
  "v_status": "E",
  "v_lastmodified_epoch": 1.460033002048079E9
}}
